id/All - Spoke to HQNT CEO; he expects the "e" to be off late next week; he said this is the same pattern as always, FWIW. They get an "e" for a few days, get their audit done and off it goes.
It will be interesting to discover when people will start noticing that this isn't dipping and feel more comfortable with it. Hopefully the $1M+ earnings generated in the last FY will help pacify and then LabQuotient sales will really convince institutions to buy when the stock is above $1.00 and hopefully $2-4 dollars by year end.
Management alone is impressive. Mr. Cohn is a West Point graduate; Larry Burden, former Senior VP with Freddie Mac; Dr. Laipply, Director of Molecular Tissue Pathology, Nichols Institute at Quest, who bought ONE Million shares on the open market, etc. Not to mention a hot new product, the aforementioned LabQuotient.
There just isn't much selling and volume this month exceeds any month in their history. I guess it's a matter of confidence and that's fine. I think that will come soon, as it has based now here for a few weeks, and that was before the $1M profit on operations just announced today and the expectation of $5M net on LabQuotient.
Let's see if a little late buying comes in again.
NEWS BRIEF:
VIENNA, Va., Apr 19, 2002 /PRNewswire-FirstCall via COMTEX/ -- H-Quotient, Inc., (OTC Bulletin Board: HQNT chart, msgs) announced earnings from operations in excess of 1,000,000 for the year ending December 31, 2001, compared with losses in every prior year. Additional earnings were recorded from investments through our subsidiary Quotient Capital Corporation. |
